Vor Biopharma Inc. (VOR) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $396.49M | +383.8% |
| 2024 | $81.95M | +161.3% |
| 2023 | $31.36M | -45.7% |
| 2022 | $57.71M | -51.8% |
| 2021 | $119.80M | +146.8% |
| 2020 | $48.54M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $396.49M | +383.8% |
| 2024 | $81.95M | +161.3% |
| 2023 | $31.36M | -45.7% |
| 2022 | $57.71M | -51.8% |
| 2021 | $119.80M | +146.8% |
| 2020 | $48.54M | — |